MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has entered into a distribution agreement with Medtronic, Inc. and SpinalGraft Technologies, LLC ("SGT"), a wholly-owned subsidiary of Medtronic. Through the agreement, MiMedx will provide its PURION® processed allograft products to Medtronic to be marketed by SGT for spinal applications.

The MiMedx PURION® processed allograft products distributed to Medtronic will be private-labeled. SGT will promote, market and sell the private-labeled allografts to its customers and end-users through-out the United States.

Parker H. Petit, MiMedx Chairman and CEO, said, "This agreement is a significant milestone for MiMedx in expanding our customer base and broadening the breadth of physicians and patients with access to our PURION® processed allografts. By partnering with Medtronic, many additional physicians and patients can be served through the extensive distribution arm and presence that Medtronic has in the spinal surgery market."

The $3.1 billion Spine business segment of Medtronic is developing many of the new standards of care in spinal and musculoskeletal therapies. Medtronic collaborates with world-renowned surgeons, researchers, and innovative partners to offer a broad range of state-of-the-art products and technologies that return patients to normal active lives more quickly, and treat a variety of musculoskeletal, neurological, orthopedic, and spinal conditions.

"We are very excited about our relationship with Medtronic," said Bill Taylor, MiMedx President and COO. "Medtronic has done an extraordinary job in serving the needs of practicing physicians. With the growing demand for an offering that can deliver the outcomes achieved by our PURION® processed allografts, it is critical to align with a partner that has unparalleled respect among physicians and extensive relationships in this sector of healthcare."

Source:

MiMedx Group, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Medtronic. (2019, June 19). MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies. News-Medical. Retrieved on May 22, 2022 from https://www.news-medical.net/news/20131001/MiMedx-Group-enters-into-distribution-agreement-with-Medtronic-and-SpinalGraft-Technologies.aspx.

  • MLA

    Medtronic. "MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies". News-Medical. 22 May 2022. <https://www.news-medical.net/news/20131001/MiMedx-Group-enters-into-distribution-agreement-with-Medtronic-and-SpinalGraft-Technologies.aspx>.

  • Chicago

    Medtronic. "MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies". News-Medical. https://www.news-medical.net/news/20131001/MiMedx-Group-enters-into-distribution-agreement-with-Medtronic-and-SpinalGraft-Technologies.aspx. (accessed May 22, 2022).

  • Harvard

    Medtronic. 2019. MiMedx Group enters into distribution agreement with Medtronic and SpinalGraft Technologies. News-Medical, viewed 22 May 2022, https://www.news-medical.net/news/20131001/MiMedx-Group-enters-into-distribution-agreement-with-Medtronic-and-SpinalGraft-Technologies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
DreaMed Diabetes and Medtronic enter strategic collaboration